Compare BridgeBio Pharma Inc (BBIO) vs Ishares Msci Thailand Etf (THD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Ishares Msci Thailand Etf — how do they compare? BridgeBio Pharma Inc trades at $84.09 (market cap $16.27B), while Ishares Msci Thailand Etf trades at $72.74. Which is the better fit depends on your goals.
| BBIO | THD | |
|---|---|---|
Market Cap | $16.27B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $90.17 | $75.05 |
52-Week Low | $44.81 | $53.63 |
Enterprise Value | $17.82B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Ishares Msci Thailand Etf
THD is a country-specific ETF that tracks the performance of the Thai equity market. It provides broad exposure to Thailand's economy across sectors like electronics, energy, and financials, with top holdings such as Delta Electronics.
Read more on THD →
